<SEC-DOCUMENT>0001019687-15-002021.txt : 20150519
<SEC-HEADER>0001019687-15-002021.hdr.sgml : 20150519
<ACCEPTANCE-DATETIME>20150519163528
ACCESSION NUMBER:		0001019687-15-002021
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150519
DATE AS OF CHANGE:		20150519
EFFECTIVENESS DATE:		20150519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		15876924

	BUSINESS ADDRESS:	
		STREET 1:		1516 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1516 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>radnet_defa.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE&nbsp;14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the Securities<BR>
Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant&#9;<FONT STYLE="font-family: Wingdings">
&yacute; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant&#9;<FONT STYLE="font-family: Wingdings">
&uml; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;
</FONT>&#9;Preliminary Proxy Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;
</FONT>&#9;Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;
</FONT>&#9;Definitive Proxy Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&yacute;
</FONT>&#9;Definitive Additional Materials</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Wingdings">&uml;
</FONT>&#9;Soliciting Material Pursuant to &sect; 240.14a-12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RADNET, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Registrant as Specified in its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>__________________________________________</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Person(s)&nbsp;Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 22pt; text-align: left"><FONT STYLE="font-family: Wingdings">&yacute;</FONT></TD><TD STYLE="text-align: justify">No fee required</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 22pt; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Fee computed on table below per Exchange Act Rules 14a-6(i)(1)&nbsp;and
0-11.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 9%; padding-left: 22pt"><font style="font-size: 10pt">(1)</font></td>
    <td style="width: 70%"><font style="font-size: 10pt">Title of each class of securities to which transaction applies:</font></td>
    <td style="width: 21%; text-align: center"><font style="font-size: 10pt">Not applicable</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(2)</font></td>
    <td><font style="font-size: 10pt">Aggregate number of securities to which transaction applies:</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">Not applicable</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(3)</font></td>
    <td><font style="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">Not applicable</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(4)</font></td>
    <td><font style="font-size: 10pt">Proposed maximum aggregate value of transaction:</font></td>
    <td style="text-align: center">&nbsp;</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(5)</font></td>
    <td><font style="font-size: 10pt">Total fee paid:</font></td>
    <td style="text-align: center">&nbsp;</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</table>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 22pt; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Fee paid previously with preliminary materials:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 22pt; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Check box if any part of the fee is offset as provided
by Exchange Act Rule 0-11(a)(2)&nbsp;and identify the filing for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule&nbsp;and the date of its filing.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 9%; padding-left: 22pt"><font style="font-size: 10pt">(1)</font></td>
    <td style="width: 91%"><font style="font-size: 10pt">Amount Previously Paid:&nbsp;&nbsp;</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(2)</font></td>
    <td><font style="font-size: 10pt">Form, Schedule&nbsp;or Registration Statement No.:&nbsp;&nbsp;</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(3)</font></td>
    <td><font style="font-size: 10pt">Filing Party:&nbsp;&nbsp;</font></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 22pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 22pt"><font style="font-size: 10pt">(4)</font></td>
    <td><font style="font-size: 10pt">Date Filed:&nbsp;&nbsp;</font></td></tr>
</table>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="width: 234px; height: 104px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RADNET, INC.<BR>
1510 Cotner Ave.<BR>
Los Angeles, CA 90025<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENT TO THE PROXY STATEMENT<BR>
FOR ANNUAL MEETING OF STOCKHOLDERS<BR>
TO BE HELD JUNE 11, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following information
relates to the proxy statement (the &ldquo;Proxy Statement&rdquo;) of RadNet, Inc. (the &ldquo;Company&rdquo;) dated April 30,
2015, furnished to the stockholders of the Company in connection with the solicitation of proxies by the Board of Directors of
the Company for the 2015 Annual Meeting of Stockholders to be held at our principal executive office at 1510 Cotner Avenue, Los
Angeles, CA 90025, on Thursday, June 11, 2015, at 10:00 a.m. (Pacific time) or at any adjournment or postponement thereof. All
capitalized terms used in this supplement to the Proxy Statement and not otherwise defined herein have the meaning ascribed to
them in the Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION
WITH THE PROXY STATEMENT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this
supplement is to update the section in the Proxy Statement entitled &ldquo;Security Ownership of Certain Beneficial Owners and
Management&rdquo; on pages 7 and 8 of the Proxy Statement to reflect the inclusion of an additional beneficial owner of 5% or more
of our common stock as of March 31, 2015. Other than the updated information below, the Proxy Statement remains unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents information concerning the beneficial ownership of the shares of our common stock as of March 31, 2015, by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">each person we know to be the beneficial owner of 5% or more of our outstanding shares of common
stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our principal executive officer, principal financial officer and each of our three other most highly
compensated executive officers as of December 31, 2014 (collectively, the &ldquo;Named Executive Officers&rdquo;);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">each director; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">all of our current executive officers and directors as a group.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise noted
below, the address of each beneficial owner listed in the table is c/o RadNet, Inc., 1510 Cotner Ave., Los Angeles, CA 90025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as indicated
by the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table
below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable
community property laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Applicable percentage
ownership is based on 43,810,280 shares of common stock outstanding on March 31, 2015. We have determined beneficial ownership
in accordance with the rules of the Securities and Exchange Commission (the &ldquo;SEC&rdquo;). In computing the number of shares
of common stock beneficially owned by a person and the percentage ownership of that person, we deemed as outstanding shares of
common stock subject to options held by that person that are currently exercisable or exercisable within 60 days of March 31, 2015.
We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 58%; border-bottom: Black 1pt solid"><font style="font-size: 10pt"><b>Name of Beneficial Owner</b></font></td>
    <td style="width: 2%">&nbsp;</td>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares Beneficially Owned</b></font></td>
    <td style="width: 2%; text-align: center">&nbsp;</td>
    <TD STYLE="width: 22%; border-bottom: Black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Percent of Shares Beneficially </b></font><br>
<font style="font-size: 10pt"><b>Owned</b></font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt"><b>5% or Greater Stockholders</b></font></td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">Richard Mashaal <sup>(1)</sup></font></td>
    <td>&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,988,118</font></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.82%</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Alan Weber<sup>(2)</sup></font></td>
    <td>&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,440,321</font></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.57%</font></td></tr>
<TR STYLE="background-color: White">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt"><b>Directors and Named Executive Officers</b></font></td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">Howard G. Berger, M.D. <sup>(3)</sup></font></td>
    <td>&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,396,140<sup>(4)</sup></font></td>
    <td style="text-align: right">&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">12.32%</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Marvin S. Cadwell</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">270,089<sup>(5)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">John V. Crues, III, M.D.</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">808,112<sup>(6)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.84%</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Norman R. Hames</font></td>
    <td>&nbsp;</td>
    <td style="text-align: right"><font style="font-size: 10pt">897,276<sup>(7)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.04%</font></td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">Lawrence L. Levitt</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">266,666<sup>(8)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Michael L. Sherman, M.D.</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">282,963<sup>(9)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">David L. Swartz</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">331,723<sup>(10)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Stephen M. Forthuber</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">552,151<sup>(11)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25%</font></td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt">Jeffrey L. Linden</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1,064,077<sup>(12)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.42%</font></td></tr>
<TR STYLE="background-color: rgb(238,238,238)">
    <td><font style="font-size: 10pt">Mark D. Stolper</font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">266,303<sup>(13)</sup></font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">*</font></td></tr>
<TR STYLE="background-color: White">
    <td><font style="font-size: 10pt"><b>All directors and executive officers as a group (13 persons)</b></font></td>
    <td><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><FONT STYLE="font-size: 10pt"><B>11,057,502</B><SUP>(14)</SUP></FONT></td>
    <td style="text-align: right"><font style="font-size: 10pt">&nbsp;</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">24.55%</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">Represents less than 1%.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">According to the Schedule 13G filed with the SEC on February 17, 2015, Mr. Mashaal maintains shared
voting power over an aggregate of 2,988,118 shares of our common stock owned by various investment vehicles managed by Rima Senvest
Management, LLC and Senvest International LLC. Mr. Mashaal is the management member of Rima Senvest Management, LLC and the president
of Senvest International LLC. Mr. Mashaal, Rima Senvest Management, LLC and Senvest International LLC disclaim ownership of the
shares other than the beneficial ownership for the limited purposes of filing the Schedule 13G with the SEC and except to the extent
of their pecuniary interest, if any, in the shares. The address set forth in the Schedule 13G filing is 540 Madison Avenue, 32<SUP>nd</SUP>
Floor, New York, New York 10022.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">According to the Schedule 13D/A filed with the SEC on June 4, 2013, Mr. Weber maintains shared
voting power over an aggregate of 2,002,615 shares of our common stock beneficially owned by JB Capital Partners LP for which Mr.
Weber is the general partner. Mr. Weber maintains sole voting power of 437,706 shares of our common stock, which includes shares
held by Mr. Weber&rsquo;s spouse and held in custodial accounts for the benefit of his children. Mr. Weber disclaims beneficial
ownership of the securities beneficially held by JB Capital Partners LP, except to the extent he has any pecuniary interest therein,
if any. The address set forth in the Schedule 13D filing is 5 Evan Place, Armonk, New York 10504.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(3)</SUP></TD><TD STYLE="text-align: justify">As a result of his stock ownership and positions as president, chief executive officer and chairman,
Dr. Berger may be deemed to be a controlling person of our Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(4)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 270,026 shares held by the Howard and Fran Berger Family Trust, or
the Trust, and 5,126,114 shares held by HFB Enterprises, LLC, or the LLC; Dr. and Mrs. Berger are co-trustees of the Trust and
are co-managers of the LLC.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(5)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 35,000 shares subject to options exercisable within 60 days of March
31, 2015 and 35,343 shares of unvested time-based restricted stock..</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(6)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 42,387 shares of unvested time-based restricted stock and 15,000
shares held by Dr. Crues&rsquo; spouse.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(7)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 175,000 shares subject to options exercisable within 60 days of March
31, 2015 and 44,004 shares of unvested time-based restricted stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(8)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 35,000 shares subject to options exercisable within 60 days of March
31, 2015 and 35,343 shares of unvested time-based restricted stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(9)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 35,000 shares subject to options exercisable within 60 days of March
31, 2015, shares 35,343 of unvested time-based restricted stock, and 1,950 shares held by Dr. Sherman&rsquo;s spouse.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(10)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 35,000 shares subject to options exercisable within 60 days of March
31, 2015, shares 35,343 of unvested time-based restricted stock, and 31,500 shares held by Mr. Swartz&rsquo;s spouse.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(11)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 200,000 shares subject to options exercisable within 60 days of March
31, 2015 and 44,004 shares of unvested time-based restricted stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(12)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 175,000 shares subject to options exercisable within 60 days of March
31, 2015 and 48,500 shares of unvested time-based restricted stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(13)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 87,500 shares subject to options exercisable within 60 days of March
31, 2014 and 42,404 shares of unvested time-based restricted stock.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><SUP>(14)</SUP></TD><TD STYLE="text-align: justify">Beneficial ownership includes 1,227,500 shares subject to options exercisable within 60 days of
March 31, 2014, 362,668 shares of unvested time-based restricted stock and 48,450 shares held indirectly by certain spouses of
the officers and directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Important Notice Regarding Availability
of Proxy Materials for the 2015 Annual Meeting of Stockholders: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This Supplement, the Proxy Statement for the 2015 Annual
Meeting of Stockholders, the Proxy Card and the 2014 Annual Report are available at www.proxyvote.com.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`>`!X``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!U`0$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MK/OM1$"E(@&D]3T%`%JXN8;6(R3RI&H[L:Y;4_'5O:Y6RMGN6Z!F^53_`%IX
MTF[U>7S)Y"$[LW]!6S8Z%86&&C@5I/\`GH_)_P#K4`<0VL^/]7/_`!+K&&VC
M/1WCP/S8_P!*1?#_`,3KCYG\5VUKG^%8$;'_`([7I0I:`//(M$^)UKDKXKTF
MZQ_#<6)`/XKBM.WU3QM8_P#(4T"QOHP.9=-N<-_WP^/T-=A10!E6&O6=^_DX
MEMKCO;W*&-Q^?7\*U!TJ*>WAN5*31+(OHPS2Q1")=JLQ7MN.<4`2T444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1144LFQ/<
M]*`(KF8@%$//<U!!8AV\R49'8>M311AW+$9'\ZM4```48Q@"C(JKJ.H6^FVK
M3SMA1T4<EO8"O/=1L_%?CUFABNWT;1R<,T9(>0?48)_04`=;K/C?PQH+%-3U
MRS@D7K'Y@9Q_P$9-<^OQG\$22%(]3FDQW2VD(_E3-'^%'@CPQ&+BYLH[N9?F
M:XOVWG/K@\"M&X\=>"-&_=-?6D`'&(X>!^0H`NZ5X^\*ZQ((K/6[4S-TCE;R
MV/X-C-=)D>O6N0M?$O@/Q4?L\=]I%ZS<>5*%R?P:MNTT:+3"!ITLD,.>;=F+
M1_@#ROX<>U`&K12`\4M`!111F@`HI,TM`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!64]P9[LJO0':*LZE="SL)9CV&!]365H!,\SR'D
M(/UH`WT4(@4=!1(P2-F/84ZH)P7*QCOUH`R_[/\`[2NC<7>#$A^1#TILVKB0
MB#3P"H.P.H_05E^.-<.FVMOI-JVVYO,@XZK&.I_'I6SH&F"QL(C(O[TJ/^`C
MTH`;-H2:C"BWKN5Q\R@\G\:K?\(-X8`^?1K64GJTJ[B?SKHZI:KD:3>D$@B!
M^1_NF@:5W8Y34/A5X&U%3OT2V@8_\M+=C&P_(UH:/H-]X;C6&RU*>_T]1@07
M3;I(Q_LOW^AKYWT2WU77]:@TRVU*=)IV(5I)GVC'/.#6K;Z]XH\`^(VM;BZF
M+0.!-;R2EXY%]L^H[USJNGTT/3GECC=1FFTKV/I>-UDC#*?S[4XL!U.*JZ?=
M17UC;WL!S'<1K(/H1FN,^+NJ2:=X)D2*5HY;F58E*M@CN<?E6TI<L>8\^E3=
M2:@MV=Z&!Z'/TI:\+^"VL3_\)'>6%Q<2R+/;[D$DA;E3VS[5[I2A/GCS(JO1
M=&HX,:74<%A^=&]3T(/XU\U_$B\NX_B!JB)=W"('4!5E8`<#M4NK>&O%WA.P
MM]974YWM756\Z"X;,>1D;@:R=??38[(Y?>,6YI.6R/I'/-&X5YQ\+_'<WB:&
M73M393J-L@<2`8\U/7'J*E^)LTL9TX1RNF=^0K$9Z5M&2DKHX*M.5.;A+='H
M6X8S1N`ZG%</\,]5:[T>XTZ:5GFLI?E+'),;<K_4?A7+_$>>>/Q!=B.>5`+=
M2`KD#H:H@]@R*,CU%8R,W_"&HVX[OL(.<\YV=:\?TQ+[5=4MM/ANY1-<9VLT
MC8&!GF@#WG</449'J*\VT_P-KUMJ]A=2ZA&T,$ZR.HE;YE'4>]3>(/".M7NK
M7E_!?(ENYWJAE8$`"@#T/(]11N'K7@ED;R^U*UL8KJ42W,GEH6E;`.">?RKT
MCPAX7U70]6N;J_NTFBE@$:JLC-@YSGF@#M**3-+0`4444`%%%%`!1110!S/C
M6Y-OI4*Y_P!9,!^0S4WA'Y]):7^_(?TK(^)<ABTFRD["XP?Q4UI^!9!+X6@8
M?WWS^=`'25`I#3OS]VIZS[67.IWD)^\NT_@:`//VC.M_&*9),M#9HJ@=A@9/
MZFO3Q7$:19&V^)NK2,.98PZGV(%=O0`M4M6_Y`][_P!<'_\`035VJ6K_`/('
MO?\`K@__`*":3V*A\2/F[X;_`/)0]*]Y6_D:TOC#)')X]E6,@LMNBOCUYKB[
M&_NM,O5O;*9H;B,G9(O5?6NM\!>%/^$XUZXEU&_)2!A+<*QS)-D^O85P0?-%
M0\SZ2M#V51XF3TM8]T\&1O%X+T=),AA:IG/TKS/XY:CNNM*TU3]U6F8?H*]F
MC18HECC4*B@*H'8"OG;XC3G6OBA):(<JDD=LOUXS^M=-?2%CR,!K6=1]+LH>
M#)9O#WQ$TP7`V$RK&_\`NN./YBOIROG7XJ69T;QW%<1#:#!%*N/5./Z"O?\`
M3+M;_2[6[0Y6:%''XC-%'2\>P\?[[A5[H^;OB7_R435?^NB_R%>\WEDFH^`'
MM9!E9-/`Z=]E>#?$S_DH>K?]=%_]!%?0UK_R*L/_`%Y#_P!`J*7VS7&.T:+7
M8^>OAE>/9?$#3,,0)&:%O?(/]0*]7^*'WM-_X'_2O'/!7'C[2<?\_H/ZU['\
M4/OZ;G_;_I5X?X2,T2]O==CEO!.K+IWBNTDWX@NP;63TR?ND_CQ^-6?B5_R,
M%W_U[K_*L>;3&B\*:9J,'#2F12P[2*Q*FIO%>J)K+KJ"]9;)-X]&`PP_/-;G
MF'KB?\B4G_7@/_0*\J\'?\CMI`[YD_\`0#7JL?\`R)2?]>`_]`KQS2A>-JUJ
M--)%^=WD;<9Z<]?:@#WRHKO_`(\I_P#KFW\JX/1(O&R^(+(ZB]P;$,WG[F3!
M&..G/6N\N_\`CRG_`.N;?RH&>(>'?^1QT7_K[_\`96KW7%>%>'?^1QT7_K[_
M`/937NU`CC!XXE_X2Z/1?[*EV/,8?,S\PP,[L8Z?C79UQ7_"<Q?\)5%HXTT[
MY+@P>=O&1@$YQCIQ2^(/'ZZ%JDMD=/:7RMN7\T*"",^E`SM**\];XFM;7J)?
M:1+!`6`<EOG13T;&.E=;K>OVNA:=]KN"7W'$:+U<^U`&K17!Z7\1)=0U2UM3
MI$@AN)?*\U'W!#[G&*[L'-`"T444`<E\1[&2^\&W7E*2\#+,,>@//Z5G?"?4
M%O/#,T0;+0W!R/9@"*[J:))X)(9!E)%*L/4'K7C?P\G?PM\2-4\+W3;5ER(2
M?XL?,I_%<T`>T5A7CFP\364Y.(;Q#;L>P<<K^?(K<]JHZOIJ:IILMJ6*.<-'
M(.J..5;\#0!!=VRPZQ;ZD!CY?*D/L>AK5%9FF73:E8-%=H$NHCY5Q'_=8=Q[
M'J*L&ZBM-D=S*J9X1VX#?CZT`7*I:O\`\@>]_P"N#_\`H)JX"35/5_\`D$7O
M_7N__H)I/8J/Q(^7_".G1ZOXGM]/E&5N!(GX[3C]:U/AYJC^&_'UO'<':CNU
MI.">.3C/YXJ'X;'_`(N'I..OFMV]C5KXH:7_`&+X\N)8OECN<7,9'8]\?C7#
M&+C%2\SZ&K)5*DZ-]&CZ/FD$,$DK'A%+$_2OE>VUV.W\;#7;F)IT6\:<Q@X+
M<G']*]PO_%2W/PAEUI7_`'DEGY9]I/ND?G7G?P7TN&^\2W=Q/"DL=O;<!UR,
ML??Z5M5O*22.'!\M&C4G->1D>/O&EIXUNK.X@LI+:2W1E;>P.X'Z5[-\+M0_
MM#P#IY)R\&86S['C],5D?%S1+4^!Y;FVM(8I+>9')CC"G&<'I63\#=2#V.JZ
M<6R8Y%F4>Q&#_(403C4:?4,1*G5PB<%:S."^)?\`R435?^NB_P`A7OD]TMEX
M$-S*P"QZ>"3_`,`KP+XF$?\`"P]6_P!]>W^R*O\`B'XD:CXCT2#0K*R:"V"*
MD@0EY)<=N!P*B,^7F\SHJT)5HTFMDM2A\-;9KSX@Z4`,[)#*WL`":]9^)_WM
M-_X'_2LSX2>";O2&EUK5(3#/,GEP0M]Y5[L1VSVK2^)Y`;3?^!_TK>C%QCJ>
M?F%6-2NW'9#-%TS^U?A,L07,L;22Q_4,?Z5YS,@CM+C;G!5FP>W%>P_#?#>!
M[0=07DX_X$:\U\7Z=_9.K:C;8PF&>//=2,C_``K8XCUV/_D24_Z\!_Z!7E7@
M[_D=](^LG_H!KU2,_P#%%)U_X\!_Z!7CNCZ@=)UFSU%4$K6^[Y"<!LC'6D![
M[BH;S_CSG_ZYM_*N!M/B;+<ZA9VO]F(/M$ZQ%O-SMR>O2N^N_P#CSG_ZYM_*
M@#Q#P[_R..B_]??_`+*U>[5X1X<(_P"$QT3U^U^G^RU>EV'C"6^\83:)'9*\
M*%OWZORH7N1[GB@1P@_Y*C:_]A)O_032^.0#XYP0,&XMP1Z\BFY'_"TK7D?\
MA)O_`$$T[QP1_P`)T.?^7FW_`)K3`F^*@`UHG'6W7^=7OB1,RII29.U;8OCW
MP*H?%5@-:.2!_HZ]3[UM?$2P>33--O0I,<:>5)C^$$#!I#.F\#VL=MX+TI$4
M#=`)&('5FY)_6N@`P<UYWX,\:65OI>DZ'<I*;S<+:,HN58?PL3VXKO+:]CNI
M940,/*;:21P?I0!9HHHH`#TKRSXM>';M$L_&.CJ?[0THAYE4<O$#G/X?R)KU
M.FLBNC*RAE(P01P10!E>&M>M?$WA^SU>S8&.X0$K_=;NOX&M8\BO+8+1_A5X
MEDE0,?!^J2_/W&GSGH3Z(?7M7J",'4,""I&00<@T`0/:I]K%S'\LN-KD?QKZ
M'Z4^ZMH+NW>WN8EEB<897'!J>B@#@=1\(^)M.9I?"/B1X4'(LM07S8OH&ZBL
M%]<^,%I*(+GPUIEVAX:2%\@C\Z]<HH`\^T>S\373K)=Z79Z>3U\J)5(_'K77
MQ:1;&-1=00W#@8S(@;'XFM*BE;2P[N][E;[%:?9_L_V:'R3SY?EC;^72EM[*
MUM<_9[>&'=U\M`N?RJQ13L(CEABGC,<L:R(>JN,@_A44%C:6I)M[:&$G@F.,
M+G\JLT8%`:VL4Y-,L9Y6DFL;=Y#U=HE)/XXIT-C9P-F&T@C;U2,#^56J*5D/
MF8W`]*9+;P38\V&.3'3>H.*EHIB&1Q1PH$BC5%'15&!3);2VG;=+;Q2'&,N@
M/\ZFHH`;L39LVC;C&W'&*A^P6?\`SZ0?]^Q5BB@"`65H&#"UA#`Y!$8XJ8@$
M8(R/>EHH`S;^*WLK&>ZALXS+$C,FR(;MV.,<5R_PYTF6"RN]6NHV6XO)"$#C
M!"`_U.?R%=UBC`]*`*HTRP\\7'V*W\X'<)/*&[/KFB73;&>;SI;.WDER#O>,
M$Y'3FK5%`%:?3K*Z?=<6<$S8QF2,,<?C4S0QO$8GC5HR,%2,C'TI]%`%&#1M
M,MIA-!86T<HZ.L0R/H>U6TACC9F1%5F.6('6GT4`%%%%`!1110!#=6T%Y:RV
MUS"DT$JE)(W7(8'J"*PM)L+GPVPL(W>XT<G_`$=F.Y[4?W#_`'D]#U'2NCHH
M`J7=ZEFD329Q)(L8P>YJ&76+.&:6)Y2&C^\-IXXS5R6&*;;YD:N`>`PSBH1I
M]J))7,*LTK$L6&2>,4`5?[=L=V!(Q.W=]T@8^M2Q:O9SI(\<I98UW,=IZ=*F
M^PVG_/M'TQ]T4Y+2WC5E2!`K<$`=:`*8UZQ8@([MR,X0_+GGFA==T^0J$GW[
MNFU20><5;6RMD8E;>,$]2%I%L+12I6VB&T87"CCG-`%9-9M38QW3,RH[%`,9
M.1U%..JVZ6D4\Y,0D3?@C.![U8-E;&,1^1'L5MP7;T/K2R6=O*H62!&51@`K
MT'I0!2?7K%#DR/M&=S;#@<9J>/4[68ML=OE4MDJ>0.OUJ4V-JP(-M&0>OR]:
M#9VY4J(E7*E>!@@'KB@"HNN6+*K"5L$X'R'K39->LT*;"7WM@8!Z>OTJW'I]
MI'&B+;Q[4/R_+T/K]:4V%HQ4M;1$K]WY>E`%>'6K.>9(HY&+N<`;342^(+,E
MMS,JAL`D'GW^E6O[,M?M$4ZPA6B.5V\"E.FV6,?98L9S]WOZT`5AKVGD?ZUA
MQD90^N*<^M6B,HW-M/\`'CBI(M)LH8?*$"LI))+#)YYJ4V-L2<P1G)R?EZT`
M13ZK:P%?,=ER`?NGH>F:KIK]FQ;+%0&VKD?>]_I5Y[*VD4*\",!C&5Z8Z4T:
M=9`<6L77/W1UH`JQZ_8OL!D8.V,J%)QQ4DFL6<,<3M*=LH)0A2<@=:=+I-G*
MZ-Y(1E;<"@QSC%2_8+5HXD>!&$0PFX9Q0!5CUNVF>01DLL<8=F((`YQCZTG]
MOZ?C)F88./N&KBV-JA8K;QC>,-A>HIK:?9L,&UB]?NT`51KUCD'S2`>AVG_/
MI4QU>T%NEP781N&()4]NM$.E6<,)B6%2.?F89//O3X]-M8K5+?R@T:$[0W/7
MK0!#_;-D8PXD)!SM^4C.!DT?VU9;L>:2=NX?*>F<9JT+2W"A1`FT9P-OJ,4P
M6%KS_H\8R"#QV)R?UH`?!<B:65/+D7RSC+#AO<58IJ*$4*HPHZ`4Z@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
9HHH`****`"BBB@`HHHH`****`"BBB@#_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
